documents: FDA-2015-E-4020-0008

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-E-4020-0008 FDA FDA-2015-E-4020 Letter from U.S. Patent and Trademark Office to Boehringer Ingelheim Corporation Other Letter(s) 2020-09-08T04:00:00Z 2020 9 2020-09-08T04:00:00Z   2020-09-08T19:48:27Z   0 0 090000648484b351

Links from other tables